The chromatin-remodeling complex ATRX/DAXX is one of the major epigenetic factors that controls heterochromatin maintenance due to its role in histone deposition. ATRX is involved in nucleosome configuration and maintenance of higher order chromatin structure, and DAXX is a specific histone chaperone for H3.3 deposition. Dysfunctions in this complex have been associated with telomere shortening, which influences cell senescence. However, data about this complex in brain tissue related to aging are still scarce. Therefore, in the present study, we analyzed ATRX and DAXX expressions in autopsied human brain specimens and the telomere length. A significant decrease in gene and protein expressions was observed in the brain tissues from the elderly compared with those from the young, which were related to short telomeres. These findings may motivate further functional analysis to confirm the ATRX-DAXX complex involvement in telomere maintenance and brain aging.
Get full access to this article
View all access options for this article.
References
1.
BaumannC., ViveirosM.M., De La FuenteR. (2010). Loss of maternal ATRX results in centromere instability and aneuploidy in the mammalian oocyte and pre-implantation embryo. PLoS Genet, 6, e1001137.
2.
BernadotteA., MikhelsonV.M., and SpivakI.M. (2016). Markers of cellular senescence. Telomere shortening as a marker of cellular senescence. Aging (Albany NY), 8, 3–11.
ClynesD., HiggsD.R., and GibbonsR.J. (2013). The chromatin remodeller ATRX: a repeat offender in human disease. Trends Biochem Sci, 38, 461–466.
5.
ClynesD., JelinskaC., XellaB., AyyubH., ScottC., MitsonM., et al. (2015). Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX. Nat Commun, 6, 7538.
De La FuenteR., ViveirosM.M., WigglesworthK., EppigJ.J. (2004). ATRX, a member of the SNF2 family of helicase/ATPases, is required for chromosome alignment and meiotic spindle organization in metaphase II stage mouse oocytes. Dev Biol, 272, 1–14.
8.
DraneP., OuararhniK., DepauxA., ShuaibM., and HamicheA. (2010). The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. Genes Dev, 24, 1253–1265.
9.
DyerM.A., QadeerZ.A., Valle-GarciaD., and BernsteinE. (2017). ATRX and DAXX: mechanisms and mutations. Cold Spring Harb Perspect Med 7,a026567.
10.
HeaphyC.M., de WildeR.F., JiaoY., KleinA.P., EdilB.H., ShiC., et al. (2011). Altered telomeres in tumors with ATRX and DAXX mutations. Science, 333, 425.
11.
HofmannT.G., StollbergN., SchmitzM.L., and WillH. (2003). HIPK2 regulates transforming growth factor-beta-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells. Cancer Res, 63, 8271–8277.
12.
HollenbachA.D., McPhersonC.J., MientjesE.J., IyengarR., and GrosveldG. (2002). Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek. J Cell Sci, 115, 3319–3330.
13.
KovatchevaM., LiaoW., KleinM.E., RobineN., GeigerH., CragoA.M., et al. (2017). ATRX is a regulator of therapy induced senescence in human cells. Nat Commun, 8, 386.
14.
LangstG., and ManelyteL. (2015). Chromatin remodelers: from function to dysfunction. Genes (Basel), 6, 299–324.
15.
LawM.J., LowerK.M., VoonH.P., HughesJ.R., GarrickD., ViprakasitV., et al. (2010). ATR-X syndrome protein targets tandem repeats and influences allele-specific expression in a size-dependent manner. Cell, 143, 367–378.
16.
Lessard-BeaudoinM., LarocheM., DemersM.J., DuclosC., DenaultJ.B., GrenierG., et al. (2016). Age-dependent differential expression of death-associated protein 6 (Daxx) in various peripheral tissues and different brain regions of C57BL/6 male mice. Biogerontology, 17, 817–828.
17.
LewisP.W., ElsaesserS.J., NohK.M., StadlerS.C., and AllisC.D. (2010). Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proc Natl Acad Sci U S A, 107, 14075–14080.
18.
LiauJ.Y., TsaiJ.H., YangC.Y., LeeJ.C., LiangC.W., HsuH.H., et al. (2015). Alternative lengthening of telomeres phenotype in malignant vascular tumors is highly associated with loss of ATRX expression and is frequently observed in hepatic angiosarcomas. Hum Pathol, 46, 1360–1366.
19.
MichodD., BartesaghiS., KhelifiA., BellodiC., BerliocchiL., NicoteraP., et al. (2012). Calcium-dependent dephosphorylation of the histone chaperone DAXX regulates H3.3 loading and transcription upon neuronal activation. Neuron, 74, 122–135.
20.
MuromotoR., SugiyamaK., TakachiA., ImotoS., SatoN., YamamotoT., et al. (2004). Physical and functional interactions between Daxx and DNA methyltransferase 1-associated protein, DMAP1. J Immunol, 172, 2985–2993.
21.
NapierC.E., HuschtschaL.I., HarveyA., BowerK., NobleJ.R., HendricksonE.A., et al. (2015). ATRX represses alternative lengthening of telomeres. Oncotarget, 6, 16543–16558.
22.
NeidleS., and ParkinsonG.N. (2003). The structure of telomeric DNA. Curr Opin Struct Biol, 13, 275–283.
23.
PiazzesiA., PapicD., BertanF., SalomoniP., NicoteraP., and BanoD. (2016). Replication-independent histone variant H3.3 controls animal lifespan through the regulation of pro-longevity transcriptional programs. Cell Rep, 17, 987–996.
24.
RitchieK., SeahC., MoulinJ., IsaacC., DickF., BerubeN.G. (2008). Loss of ATRX leads to chromosome cohesion and congression defects. J Cell Biol, 180, 315–324.
25.
SalomoniP. (2013). The PML-interacting protein DAXX: histone loading gets into the picture. Front Oncol, 3, 152.
26.
SaretzkiG. (2018). Telomeres, telomerase and ageing. Subcell Biochem, 90, 221–308.
27.
SchindelinJ., Arganda-CarrerasI., FriseE., KaynigV., LongairM., PietzschT., et al. (2012). Fiji: an open-source platform for biological-image analysis. Nat Methods, 9, 676–682.
28.
SchmittgenT.D., and LivakK.J. (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc, 3, 1101–1108.
29.
SchwartzentruberJ., KorshunovA., LiuX.Y., JonesD.T., PfaffE., JacobK., et al. (2012). Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature, 482, 226–231.
30.
SeahC., LevyM.A., JiangY., MokhtarzadaS., HiggsD.R., GibbonsR.J., et al. (2008). Neuronal death resulting from targeted disruption of the Snf2 protein ATRX is mediated by p53. J Neurosci, 28, 12570–12580.
31.
VandesompeleJ., De PreterK., PattynF., PoppeB., Van RoyN., De PaepeA., et al. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol, 3, research0034.1.
32.
VictorelliS., and PassosJ.F. (2017). Telomeres and cell senescence—size matters not. EBioMedicine, 21, 14–20.
33.
WatsonL.A., SolomonL.A., LiJ.R., JiangY., EdwardsM., Shin-YaK., et al. (2013). Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span. J Clin Invest, 123, 2049–2063.
34.
World Health Organization. (2015). World report on ageing and health. Available at www.who.int/life-course/publications/2015-ageing-report/en/, WHO Library Cataloguing-in-Publication Data. (accessed January15, 2018.)
35.
WongL.H., McGhieJ.D., SimM., AndersonM.A., AhnS., HannanR.D., et al. (2010). ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells. Genome Res, 20, 351–360.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
